Trial intelligence / Profile preview

Desmopressin and Dexamethasone for Pulmonary Hemorrhage in Leptospirosis

NCT00592566Phase 3Terminated

Sponsor
Mahidol University
Start
Jul 2003
Primary completion
Oct 2006
Modality
Peptides, Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, open-label trial of desmopressin and dexamethasone in leptospirosis and pulmonary hemorrhage (3 arms), sponsored by Mahidol University. Primary endpoint: Survival. Started Jul 2003; status: terminated.

02

Drugs

desmopressindexamethasone
03

Conditions

leptospirosispulmonary hemorrhage

Beyond the preview

Go deeper on NCT00592566.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00592566.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call